Oxaliplatin-induced haemolytic anaemia

Lancet. 1999 Oct 2;354(9185):1179-80. doi: 10.1016/s0140-6736(99)03827-1.

Abstract

A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Aged
  • Anemia, Hemolytic / chemically induced*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / blood
  • Colorectal Neoplasms / pathology
  • Fatal Outcome
  • Female
  • Humans
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Organoplatinum Compounds / adverse effects*
  • Organoplatinum Compounds / blood
  • Oxaliplatin

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Oxaliplatin